Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Using quality-adjusted progression-free survival as an outcome measure to assess the benefits of cancer drugs in randomized-controlled trials: case of the BOLERO-2 trial
PaperCitations, authors & open-access status
Using quality-adjusted progression-free survival as an outcome measure to assess the benefits of cancer drugs in randomized-controlled trials: case of the BOLERO-2 trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 16 citations, 2014 year and green oa status.
16
Citations
2014
Year
green
OA Status